Le Lézard
Classified in: Health
Subjects: CCA, TDS, PET

Elanco to Participate in Upcoming Investor Conferences


GREENFIELD, Ind., Feb. 22, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.

On Thursday, February 29, Todd Young, executive vice president and CFO, will participate in a fireside chat at the Bank of America 2024 Animal Health Summit at 2:10 p.m. ET.

On Monday, March 4, Jeff Simmons, president and CEO, will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference at 10:30 a.m. ET.

On Tuesday, March 12, Todd Young, executive vice president and CFO, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference at 4:05 p.m. ET

Live audio webcasts will be available in the "Events and Presentations" section of Elanco's investor website. Replays will be available for approximately 30 days.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose? all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com

Investor Contact: Katy Grissom (317) 273-9248 [email protected]
Media Contact: Colleen Parr Dekker (317) 989-7011 [email protected]

SOURCE Elanco Animal Health


These press releases may also interest you

at 16:10
Prothena Corporation plc , a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the first quarter of 2024 and provided...

at 16:10
Myomo, Inc. ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended...

at 16:10
QuidelOrtho Corporation (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, today announced financial results for the first...

at 16:10
Acadia Pharmaceuticals Inc. today announced its financial results for the first quarter ended March 31, 2024. "In the first quarter of 2024, Acadia delivered net product sales of $205.8 million, representing 74% revenue growth year over year,...

at 16:10
Zai Lab Limited today announced financial results for the first quarter of 2024, along with recent product highlights and corporate updates. "Our first quarter results demonstrate strong commercial execution and pipeline progress across our...

at 16:10
ChromaDex Corp. today announced financial results for the first quarter of 2024. First Quarter 2024 Financial and Recent Operational Highlights Total net sales were $22.2 million, with $17.4 million from Tru Niagen®. Solid gross margin of...



News published on and distributed by: